PPT-Improving Pain Control and Reducing Opioid Related Adverse Events

Author : mitsue-stanley | Published Date : 2018-10-29

Adam Novak Manager Patient Safety amp Quality Michigan Health amp Hospital Association Keystone Center February 7 2017 Objectives Describe the MHA Keystone Center

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Improving Pain Control and Reducing Opio..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Improving Pain Control and Reducing Opioid Related Adverse Events: Transcript


Adam Novak Manager Patient Safety amp Quality Michigan Health amp Hospital Association Keystone Center February 7 2017 Objectives Describe the MHA Keystone Center Pain Management activities and tools involved in reducing opioidrelated adverse . OBJECTIVES. Describe Adverse Events, Risks and Problems that can Occur in . H. uman . S. ubjects . R. esearch . C. ompliance with Safety . R. eporting . R. egulations in Clinical Research. Identify Current Systems of Patient Care and Patient Safety in Research. . Which Form 4 to Use?. Reason for Reporting Unanticipated Problems. “to assure the protection of the rights and welfare of the human subjects”. UTHSC IRB Submission Forms. 4a: Reportable local adverse events. Kenneth L. Kirsh. , . Ph.D.. Clinical Research Educator and Research Scientist. Millennium . Laboratories. Millennium Research Institute. San Diego, CA. The Opioid Pendulum. Opiophobia. Balance of Addiction Medicine and Pain Management Principles. 2004-2012. Office of Health Informatics and. AIDS/HIV and Hepatitis C Program. Bureau of Communicable Diseases and Emergency Preparedness,. Division . of Public Health. Wisconsin Department of Health Services. Rachel Phillips & Victoria Cornelius. Review. “recommended improvements in the accuracy of harm data in RCT reports and a need to standardize practices for reporting.”. Review. “found that methods used to collect adverse event data, the frequency of collection, and the selection criteria used by authors for reporting adverse events vary substantially, and these events are often inadequately reported.”. Annie Ottney, . PharmD. , BCPS. Learning Objective. Identify non-opioid medications that can be used in the management of chronic pain. Opioid Epidemic . Concurrent use of opioids and benzodiazepines across United States is HIGH. MPhA. MTM Fall Symposium. Kathryn Perrotta, . PharmD. , MBA, BCPS. November 16, 2012. Disclosure Statement. Define the health economic impact of the use of . opioid. analgesics in the treatment of pain . The Role of Opioid Medication in Chronic Pain Management Lorraine Widdall, MS APRN BC Interventional Spine and Pain Center Effective December 15, 2013 Emergency rule that temporarily adds provisions under P.L. 185-2013 (SEA246) regarding physicians prescribing opioids for chronic pain. MODULE 3 Adverse events following immunizationOverviewUnder recommended conditions all vaccines used in national immunization programmes are safe and e31ective if used correctly In practice however no Nathaniel Katz, MD, MS. Associate Professor of Anesthesia, Tufts University. CEO, Analgesic Solutions. . IMMPACT-XXI . July 26-27, 2018 Washington, DC. Scenarios Hypotheses. Non-opioid analgesic. A Responsibility to Protect. C. Scott Anthony, D.O.. Pain Management of Tulsa. Disclosure. I . have no relevant financial relationships or affiliations with commercial interests to disclose.. Recent Actions. Shared Learning Call . Cohort II Kickoff. September 23, 2021. Agenda. Why Are We Here?. Source: . Link to CDPHE Drug Overdose Dashboard. Goals. Reduce risky opioid prescribing by 5%. Risky = morphine equivalent dose (MED) of 90 or higher, co-prescribed benzodiazepines . Orrin Franko. Orthopedic & Hand Specialist. Disclosures. Owner/Founder: www.TopOrthoApps.com. Owner/Founder: www.SurgiSurvey.com. No relevant financial disclosures related to the topic of this presentation.. Investigator Kick-off Meeting. January 30-31, Clearwater, Florida. Jodie Riley, MISM and Robert Silbergleit. Adverse Events. Adverse Events (AEs) are “. . . any . untoward. medical occurrence in a subject that was not previously identified which does not necessarily have a causal relationship to the study drug…” .

Download Document

Here is the link to download the presentation.
"Improving Pain Control and Reducing Opioid Related Adverse Events"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents